epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Kisqali
    ribociclib
  • remove Maxitrol
    neomycin/ polymyxin B/ dexamethasone ophthalmic
  • remove Myrbetriq
    mirabegron
  • remove Orencia
    abatacept
  • remove Previfem
    norgestimate/ ethinyl estradiol

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Kisqali (ribociclib) + Previfem (norgestimate/ ethinyl estradiol)

Monitor/Modify Tx


ribociclib + ethinyl estradiol (contraceptive)

monitor ECG, electrolytes, CBC, thrombosis s/sx, especially if oral ethinyl estradiol dose >35 mcg/day: combo may incr. levels of both drugs, risk of QT prolongation, cardiac arrhythmias, myelosuppression, thromboembolism, other adverse effects (hepatic metabolism inhibited)

Smiley face Smiley face Myrbetriq (mirabegron) + Previfem (norgestimate/ ethinyl estradiol)

Monitor/Modify Tx


mirabegron + ethinyl estradiol (contraceptive)

monitor BP: combo may incr. risk of HTN (additive effects)

Caution Advised

Smiley face Smiley face Maxitrol (neomycin/ polymyxin B/ dexamethasone ophthalmic) + Orencia (abatacept)

Caution Advised


dexamethasone ophthalmic + abatacept

caution advised: combo may incr. risk of serious infection (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information